Cargando…

MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer

OBJECTIVE: To study the expression of MRPL13 in breast cancer tissues using TCGA database, analyze the correlation between the expression and clinicopathological characteristics of patients, and explore the role of MRPL13 in the development of breast cancer (BC). METHODS: The BC mRNA data and clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Zuo, Suo, Huandan, Zhang, Lei, Jin, Zining, Wang, Zhen, Wang, Danyu, Wu, Ming, Peng, Nanxi, Zhao, Yujie, Chen, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708783/ https://www.ncbi.nlm.nih.gov/pubmed/33273831 http://dx.doi.org/10.2147/OTT.S263998

Ejemplares similares

MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer
por: Xu, Haoya, et al.
Publicado: (2021)

MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma
por: Hu, Yangyang, et al.
Publicado: (2023)

Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer
por: Zeng, Yangyang, et al.
Publicado: (2021)

Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer
por: Ye, Hongshan, et al.
Publicado: (2021)

Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature
por: Ma, Wei, et al.
Publicado: (2020)

Potential roles of synaptotagmin family members in cancers: Recent advances and prospects
por: Suo, Huandan, et al.
Publicado: (2022)

Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma
por: Zhong, Xugang, et al.
Publicado: (2023)

MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer
por: Jing, Chuanqing, et al.
Publicado: (2021)

HSPB8 is a Potential Prognostic Biomarker that Correlates With Immune Cell Infiltration in Bladder Cancer
por: Tan, Zhiyong, et al.
Publicado: (2022)

PER1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Ovarian Cancer
por: Chen, Mali, et al.
Publicado: (2021)

The cancer‐associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer
por: Du, YiHeng, et al.
Publicado: (2021)

ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer
por: Zhang, Junchang, et al.
Publicado: (2022)

Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer
por: Xie, Xiaodong, et al.
Publicado: (2023)

Ano1 is a Prognostic Biomarker That is Correlated with Immune Infiltration in Colorectal Cancer
por: Chen, Jun, et al.
Publicado: (2022)

Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer
por: Chen, Fei, et al.
Publicado: (2021)

Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer
por: Li, Tian-Hao, et al.
Publicado: (2022)

Downregulation of FPN1 acts as a prognostic biomarker associated with immune infiltration in lung cancer
por: Liu, Bing, et al.
Publicado: (2021)

DISC1 as a prognostic biomarker correlated with immune infiltrates in gastric cancer
por: Zheng, Shiyao, et al.
Publicado: (2023)

INHBB is a novel prognostic biomarker and correlated with immune infiltrates in gastric cancer
por: Yu, Weifeng, et al.
Publicado: (2022)

Prognostic Biomarker SPOCD1 and Its Correlation with Immune Infiltrates in Colorectal Cancer
por: Gan, Lin, et al.
Publicado: (2023)

FN1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers
por: Wang, Han, et al.
Publicado: (2022)

SNHG10 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Prostate Cancer
por: Chen, Qiang, et al.
Publicado: (2021)

DCK is an Unfavorable Prognostic Biomarker and Correlated With Immune Infiltrates in Liver Cancer
por: Hu, Shu Fang, et al.
Publicado: (2020)

PDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancer
por: Hu, Liya, et al.
Publicado: (2020)

HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer
por: Liu, Chengdong, et al.
Publicado: (2021)

PODN is a prognostic biomarker and correlated with immune infiltrates in osteosarcoma
por: Yao, Feng, et al.
Publicado: (2021)

TMEM33 as a Prognostic Biomarker of Cervical Cancer and Its Correlation with Immune Infiltration
por: Zhang, Hui, et al.
Publicado: (2023)

AGT May Serve as a Prognostic Biomarker and Correlated with Immune Infiltration in Gastric Cancer
por: Wu, Fanqi, et al.
Publicado: (2022)

Hsa_circ_0072309 is a prognostic biomarker and is correlated with immune infiltration in gastric cancer
por: Xu, Bei-Bei, et al.
Publicado: (2023)

Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
por: Wu, Miaowei, et al.
Publicado: (2020)

CFP is a prognostic biomarker and correlated with immune infiltrates in Gastric Cancer and Lung Cancer
por: Cui, Guoliang, et al.
Publicado: (2021)

ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer
por: Jin, Yuchen, et al.
Publicado: (2022)

RAI14 Is a Prognostic Biomarker and Correlated With Immune Cell Infiltrates in Gastric Cancer
por: Xiao, Yu, et al.
Publicado: (2020)

EDIL3 is a potential prognostic biomarker that correlates with immune infiltrates in gastric cancer
por: Ke, Bin, et al.
Publicado: (2023)

LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer
por: Shi, Jingqi, et al.
Publicado: (2020)

CCDC134 as a Prognostic-Related Biomarker in Breast Cancer Correlating With Immune Infiltrates
por: Huang, Zhijian, et al.
Publicado: (2022)

CTHRC1 is a Potential Prognostic Biomarker and Correlated with Macrophage Infiltration in Breast Cancer
por: Wang, Zejun, et al.
Publicado: (2022)

TILRR (FREM1 isoform 2) is a prognostic biomarker correlated with immune infiltration in breast cancer
por: Xu, Xiao-Yi, et al.
Publicado: (2020)

KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer
por: Qiu, Meng-jun, et al.
Publicado: (2021)

UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer
por: Wang, Zijun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qjv7lsqkdk98apq3923r5d0616